Chromogranin A and other enteroendocrine markers in inflammatory bowel disease
- 1 August 2016
- journal article
- review article
- Published by Elsevier in Neuropeptides
- Vol. 58, 127-134
Abstract
No abstract availableKeywords
This publication has 116 references indexed in Scilit:
- 5-Hydroxytryptamine (serotonin) in the gastrointestinal tractCurrent Opinion in Endocrinology, Diabetes and Obesity, 2013
- Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut–brain axisNeuropeptides, 2012
- Overlap of Endocrine Hormone Expression in the Mouse Intestine Revealed by Transcriptional Profiling and Flow CytometryEndocrinology, 2012
- Intestinal feedback signaling and satietyPhysiology & Behavior, 2011
- Sex‐dependent control of murine emotional‐affective behaviour in health and colitis by peptide YY and neuropeptide YBritish Journal of Pharmacology, 2011
- Gut hormones: emerging role in immune activation and inflammationClinical and Experimental Immunology, 2010
- Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): its therapeutic potential in inflammatory diseaseClinical and Experimental Immunology, 2009
- Melanin-concentrating hormone (MCH) modulates C difficile toxin A-mediated enteritis in miceGut, 2008
- Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapyAnnals of the Rheumatic Diseases, 2007
- Enteroendocrine cells express functional Toll-like receptorsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2007